Organisation: forskargrupp


Ämnesklassifikation (UKÄ)

  • Endokrinologi och diabetes


This project aims to develop incretin therapy as a glucose-reducing strategy in type 2 diabetes (T2D). Its particular focus is to understand the mechanisms of incretin therapy and to optimize its clinical positioning. This mission is achieved by an interdisciplinary approach with complementary studies in subjects with T2D, healthy volunteers and experimental animals.

Senaste forskningsoutput

Alsalim, W., 2020, Lund: Lund University, Faculty of Medicine. 69 s.

Forskningsoutput: AvhandlingDoktorsavhandling (sammanläggning)

Bo Ahrén, Yamada, Y. & Seino, Y., 2020, I : Journal of the Endocrine Society. 4, 2, bvz036.

Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

Visa alla (46)